No Data
No Data
No Data
No Data
No Data
10 Micro-Cap Healthcare Stocks Insiders Are Buying
Yahoo FinanceApr 14 15:00 ET
Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed slightly lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested
BenzingaApr 12 08:36 ET
Buy Rating Affirmed for Palatin Technologies Following Successful Phase 3 Trial of PL9643 for Dry Eye Disease
TipRanksApr 8 11:05 ET
Palatin Technologies Shares Rise 27% After Positive Trial Results for PL9643
By Chris Wack Palatin Technologies shares were up 27% to $2.24 after the company said it saw positive topline results for its Phase 3 pivotal clinical trial evaluating the safety and efficacy of PL96
WSJApr 8 10:46 ET
Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data
On Monday, Palatin Technologies Inc. (NYSE:PTN) announced the presentation of topline results for its Phase 3 PL9643 MELODY-1 trial, which evaluated the safety and efficacy of PL9643 versus vehicle in
BenzingaApr 8 10:02 ET
Palatin Stock Jumps 16% on Positive Phase 3 Data for Eye Drug
Seeking AlphaApr 8 09:49 ET
No Data
No Data